Article

Driver Mutations and Malignant Pleural Effusion in Non-small Cell Lung Cancer

2025-04-21

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold> Malignant pleural effusion (MPE) complicates approximately 50% of non-small cell lung cancer (NSCLC) cases, signaling advanced disease and poor patient outcomes. While driver mutations including programmed death-ligand 1 (PD-L1), anaplastic lymphoma kinase (ALK), proto-oncogene tyrosine-protein kinase-1 (ROS1), and threonine at amino acid position 790 (T790M) are...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d8587797-2515-57e6-8a7b-5b5b3a982900
DOI: 10.21203/rs.3.rs-6275845/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Driver Mutations and Malignant Pleural Effusion in Non-small Cell Lung CancerDOI 10.21203/rs.3.rs-6275845/v1Read

Clinical and Molecular Features of Malignant Pleural Effusion in Non-Small Cell Lung Cancer (NSCLC) of a Caucasian Population.Semantic proximity Read

NSCLC: An Update of Driver Mutations, Their Role in Pathogenesis and Clinical Significance.Semantic proximity Read

Lung adenocarcinoma with malignant serous effusions: A comprehensive clinicopathologic, molecular, and outcome analysis.Semantic proximity Read

Differences between lung adenocarcinoma and lung squamous cell carcinoma: Driver genes, therapeutic targets, and clinical efficacySemantic proximity Read

Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update.Semantic proximity Read

Advances in Targeted Therapy Against Driver Mutations and Epigenetic Alterations in Non-Small Cell Lung CancerSemantic proximity Read

Advancements in NSCLC: From Pathophysiological Insights to Targeted Treatments.Semantic proximity Read

Driver genes in non-small cell lung cancer: Characteristics, detection methods, and targeted therapiesSemantic proximity Read

Clinicopathological and molecular characteristics associated with PD-L1 expression in non-small cell lung cancer: a large-scale, multi-center, real-world study in China.Semantic proximity Read

Metastatic non-small-cell lung cancer without driver mutations: projections by therapy line in Western Europe, 2021-2026.Semantic proximity Read

Landscape of Genomic Alterations and PD-L1 Expression in Early-Stage Non-Small-Cell Lung Cancer (NSCLC)-A Single Center, Retrospective Observational Study.Semantic proximity Read

[Advances on driver oncogenes of non-small cell lung cancer].Semantic proximity Read